Document is current
Any future updates will be listed below
-
Authors
Luo, Lisi
Yang, Huijie
Huang, Junfeng
Chen, Difei
He, Yushan
Lin, Jinsheng
Zeng, Haikang
Hua, Chu
Lin, Zikai
Wu, Minting
Ma, Yuqin
Deng, Qilin
Liu, Ming
Li, Shiyue https://orcid.org/0000-0001-9622-5623
-
Funding
Funding for this research was provided by:
Innovation team of respiratory diseases and regenerative medicine (2021KCXTD028)
Zhongnanshan medical foundation of Guangdong Province (ZNSA-2020013)
Clinical High-tech Project of Guangzhou (2023C-GX04)
Guangdong Province Key Field Research and Development Program (2023B1111050006)
- License Information
-
More Information
Article History
Received: 4 October 2024
Accepted: 6 March 2025
First Online: 18 March 2025
Declarations
:
: The study received ethical approval from the Institutional Review Board of the First Affiliated Hospital of Guangzhou Medical University (Ethics Review Number ES-2024-K075-01). The project title is “Exploration of the role and application of airway basal stem cell-derived extracellular vesicles (BSC-EVs) in respiratory diseases”, and the approval date is 13/6/2024. Informed consent was obtained from all human subjects before their participation. All procedures involving animals were approved by the Laboratory Animal Ethics Committee of Affiliated First Hospital of Guangzhou Medical University (No. 20240726). Title of the approved project: Therapeutic effects and mechanisms of airway basal stem cell-derived extracellular vesicles (BSC-EVs) in pulmonary fibrosis repair, and the approval date is 4/9/2024.
: Not applicable.
: The authors declare that they have no competing interests.
